HomeCompareCTCX vs PLD

CTCX vs PLD: Dividend Comparison 2026

CTCX yields 1013.68% · PLD yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTCX wins by $21217097.10M in total portfolio value
10 years
CTCX
CTCX
● Live price
1013.68%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21217097.13M
Annual income
$17,768,877,895,719.51
Full CTCX calculator →
PLD
PLD
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full PLD calculator →

Portfolio growth — CTCX vs PLD

📍 CTCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTCXPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTCX + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTCX pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTCX
Annual income on $10K today (after 15% tax)
$86,163.20/yr
After 10yr DRIP, annual income (after tax)
$15,103,546,211,361.58/yr
PLD
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, CTCX beats the other by $15,103,546,210,597.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTCX + PLD for your $10,000?

CTCX: 50%PLD: 50%
100% PLD50/50100% CTCX
Portfolio after 10yr
$10608548.58M
Annual income
$8,884,438,948,309.35/yr
Blended yield
83.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CTCX
No analyst data
Altman Z
-56.1
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+172.0% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTCX buys
0
PLD buys
0
No recent congressional trades found for CTCX or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTCXPLD
Forward yield1013.68%4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR0%5%
Portfolio after 10y$21217097.13M$28.0K
Annual income after 10y$17,768,877,895,719.51$899.19
Total dividends collected$20954125.95M$6.4K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CTCX vs PLD ($10,000, DRIP)

YearCTCX PortfolioCTCX Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$112,068$101,368.47$11,120$420.00+$100.9KCTCX
2$1,181,615$1,061,701.90$12,357$458.31+$1.17MCTCX
3$11,726,249$10,461,920.38$13,721$499.76+$11.71MCTCX
4$109,578,123$97,031,037.37$15,227$544.58+$109.56MCTCX
5$964,654,833$847,406,240.94$16,885$593.02+$964.64MCTCX
6$8,004,158,004$6,971,977,332.68$18,713$645.34+$8004.14MCTCX
7$62,629,410,485$54,064,961,420.43$20,724$701.81+$62629.39MCTCX
8$462,375,346,702$395,361,877,482.99$22,938$762.73+$462375.32MCTCX
9$3,222,634,793,872$2,727,893,172,901.40$25,372$828.41+$3222634.77MCTCX
10$21,217,097,125,163$17,768,877,895,719.51$28,047$899.19+$21217097.10MCTCX

CTCX vs PLD: Complete Analysis 2026

CTCXStock

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Full CTCX Calculator →

PLDREIT

PLD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in PLD shares.

Full PLD Calculator →
📬

Get this CTCX vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTCX vs SCHDCTCX vs JEPICTCX vs OCTCX vs KOCTCX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.